Tarloxotinib

Indicated For

EGFR exon 20 insertion NSCLC, HER2-activating mutation NSCLC

About This Medication

# Tarloxotinib Patient Assistance Program Guide ## Important Notice Based on available search results as of March 2026, specific patient assistance program details for Tarloxotinib (Tarloxotinib Bromide) could not be located. The information below provides general guidance on accessing this medication and resources for obtaining assistance. ## About Tarloxotinib Tarloxotinib is a **hypoxia-activated prodrug** designed to treat advanced cancers, particularly non-small cell lung cancer (NSCLC) and head and neck cancers. The drug works by targeting low-oxygen areas within tumors, where it converts to a potent pan-HER kinase inhibitor. This targeted mechanism is designed to minimize side effects compared to systemic cancer treatments. Tarloxotinib has demonstrated efficacy in patients with specific genetic mutations, including EGFR exon 20 insertions, HER2-activating mutations, and NRG1 fusions. Clinical trials have shown the drug to be well-tolerated, with low rates of severe toxicities such as rash and diarrhea. ## Finding Assistance for Tarloxotinib ### Manufacturer Support Tarloxotinib is currently being developed and studied under Convert Pharmaceuticals and previously Rain Therapeutics. To locate the most current patient assistance program: 1. **Contact the manufacturer directly** through their official website or patient support line 2. **Use RxAssist** (rxassist.org), a comprehensive database of pharmaceutical patient assistance programs 3. **Call 1-800-4-CANCER** (National Cancer Institute) for guidance on accessing investigational cancer medications ### General Cancer Medication Assistance If a manufacturer-specific program is unavailable, several organizations provide financial assistance for cancer medications: - **Good Days** (formerly Chronic Disease Fund): Provides direct financial assistance for many newer cancer drugs - **Patient advocacy organizations**: Many cancer-specific nonprofits offer co-pay assistance and medication access programs - **Hospital financial assistance**: If receiving treatment at a cancer center, ask about institutional assistance programs ## Income Eligibility Income thresholds vary by program. Most pharmaceutical patient assistance programs use federal poverty level (FPL) guidelines, typically ranging from 100% to 400% of FPL depending on household size. Without access to Tarloxotinib's specific program details, contact the manufacturer or RxAssist for exact income limits. ## Insurance Requirements Patient assistance programs typically have different eligibility criteria based on insurance status: - **Uninsured patients**: Usually eligible for maximum assistance - **Underinsured patients**: May qualify if out-of-pocket costs exceed program thresholds - **Medicare patients**: Eligibility varies; some programs exclude Medicare beneficiaries - **Medicaid patients**: Eligibility varies by state and program Verify insurance requirements with the specific program before applying. ## How to Apply ### Step 1: Gather Required Documentation Typically needed: - Proof of income (tax returns, pay stubs, or benefit statements) - Proof of citizenship or residency - Insurance information (if applicable) - Prescription from your oncologist - Medical records confirming diagnosis ### Step 2: Contact the Program - Call the manufacturer's patient support line - Visit the manufacturer's website for online application - Ask your oncologist's office to submit on your behalf - Use RxAssist to locate and apply through their database ### Step 3: Submit Application Applications can typically be submitted by: - Phone - Online portal - Mail - Through your healthcare provider ### Step 4: Await Approval Processing times vary but typically range from 5-10 business days. You'll receive notification by phone, mail, or email. ## Timeline and Medication Delivery Once approved: - **Delivery method**: Medications are typically shipped directly to your home or healthcare provider - **Processing time**: Allow 5-10 business days for approval after submission - **Shipping time**: Allow 3-7 business days for delivery after approval - **Total timeline**: Expect 2-3 weeks from application to receipt ## What If Your Application Is Denied? If denied: 1. Request a written explanation of the denial reason 2. Ask if you can reapply with additional documentation 3. Contact your oncologist about alternative funding sources 4. Explore other assistance programs through cancer advocacy organizations 5. Ask about clinical trial enrollment, which may provide free medication ## Reauthorization and Refills Most programs require periodic reauthorization. You may need to: - Resubmit income documentation annually - Provide updated medical records - Confirm continued eligibility Your healthcare provider or the assistance program will notify you when reauthorization is needed. ## Important Disclaimer This guide provides general information about accessing cancer medications through patient assistance programs. Specific details about Tarloxotinib's assistance program were not available at the time of publication. Program eligibility, requirements, and benefits change frequently. Always verify current information directly with the manufacturer, RxAssist, or your healthcare provider. This guide is not a substitute for professional medical or financial advice. Consult your oncologist and financial counselor for personalized guidance.

Program information last verified: March 30, 2026